Tuberculosis in special populations (Q37855145)

24 August 2017

1 reference

title

Tuberculosis in special populations (English)

1 reference

24 August 2017

0 references

Miguel Santín Cerezales

series ordinal

1 reference

24 August 2017

Enrique Navas Elorza

series ordinal

1 reference

24 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21420563

27 November 2024

publication date

1 March 2011

1 reference

24 August 2017

March 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21420563

full work available at URL

27 November 2024

https://api.elsevier.com/content/article/PII:S0213005X11700143?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0213-005X(11)70014-3

https://api.elsevier.com/content/article/PII:S0213005X11700143?httpAccept=text/plain

27 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0213-005X(11)70014-3

Infectious Diseases and Clinical Microbiology

27 November 2024

published in

1 reference

24 August 2017

volume

29 Suppl 1

1 reference

24 August 2017

page(s)

20-25

1 reference

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG).

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Update on rifampin and rifabutin drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

HIV-associated tuberculosis: diagnostic and treatment challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Timing of initiation of antiretroviral drugs during tuberculosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis manifested by immune reconstitution inflammatory syndrome during HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Mycobacterium tuberculosis infection in recipients of solid organ transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis after Solid‐Organ Transplant: Incidence, Risk Factors, and Clinical Characteristics in the RESITRA (Spanish Network of Infection in Transplantation) Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis cases associated with infliximab and etanercept

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

1 reference

7 January 2021

QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Screening for tuberculosis infection prior to initiation of anti-TNF therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Childhood pulmonary tuberculosis: old wisdom and new challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

The prevalence of symptoms associated with pulmonary tuberculosis in randomly selected children from a high burden community

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Clinical practice: diagnosis of childhood tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Ethambutol in tuberculosis: time to reconsider?

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Latent tuberculosis infection in children: a call for revised treatment guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Pregnancy and tuberculosis: influence of treatment on perinatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis in pregnancy: interactions, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

The maternal and fetal effects of tuberculosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis and aging: a global health problem

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Does aging modify pulmonary tuberculosis?: A meta-analytical review.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Overt and cryptic miliary tuberculosis misdiagnosed until autopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Advanced survey of tuberculosis transmission in a complex socioepidemiologic scenario with a high proportion of cases in immigrants

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

[Tuberculosis and immigration in Spain. Evidences and controversies]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Continued low rates of transmission of Mycobacterium tuberculosis in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Changes in the transmission of tuberculosis in New York City from 1990 to 1999

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Molecular epidemiology of Mycobacterium tuberculosis infection in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

[Tuberculosis in immigrants: clinical and epidemiological differences as compared to the native population (1999-2002)].

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis and immigration in a health sanitary area in Madrid, Spain. Trends in 1994-2003

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Clinicoepidemiological features of immigrants with tuberculosis living in Madrid, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

[Impact of immigration on drug resistance to Mycobacterium tuberculosis in Castellon (Spain): 1995-2003]

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Tuberculosis treatment adherence and fatality in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

Cost-effectiveness of tuberculosis control strategies among immigrants and refugees

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970014-3

7 January 2021

American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016/S0213-005X(11)70014-3

Prevention and control of tuberculosis in facilities providing long-term care to the elderly. Recommendations of the Advisory Committee for Elimination of Tuberculosis

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0213-005X(11)70014-3

Risk of tuberculosis in dialysis patients: a population-based study

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0213-005X(11)70014-3

Epidemiology and clinical features of tuberculosis in immigrants at an infectious diseases department in Madrid

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0213-005X(11)70014-3

27 November 2024

Identifiers

DOI

1 reference

release_mx4atygaqbhtdbtqg7jcjkzmya

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mx4atygaqbhtdbtqg7jcjkzmya

24 November 2022

mapped directly with Wikidata item

1 reference